Reduction of Synaptophysin Immunoreactivity in the Prefrontal Cortex of Subjects With Schizophrenia
- 1 October 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 54 (10) , 943-952
- https://doi.org/10.1001/archpsyc.1997.01830220065010
Abstract
Background: Multiple lines of evidence indicate that the prefrontal cortex is a site of dysfunction in schizophrenia. However, the apparent absence of gross structural abnormalities in this area suggests that the pathophysiological characteristics of schizophrenia may involve more subtle disturbances in prefrontal cortical circuitry, such as alterations in synaptic connectivity and transmission. In this study, immunoreactivity for synaptophysin, an integral membrane protein of small synaptic vesicles, was used to assess the integrity of cortical synaptic circuitry in schizophrenia. Methods: Using immunocytochemical techniques and adjusted optical density measurements, we examined synaptophysin immunoreactivity in prefrontal cortical areas 9 and 46 and in area 17. (the primary visual cortex) from 10 pairs of case subjects with schizophrenia and control subjects matched on a pairwise basis for age, sex, race, and postmortem interval, and in 5 matched pairs of nonschizophrenic psychiatric case subjects and normal control subjects. Results: Compared with levels found in matched control subjects, synaptophysin immunoreactivity in areas 46 and 9 was significantly decreased (P<.001 andP<.008, respectively) across all cortical layers in the case subjects with schizophrenia. In contrast, no differences were observed in area 17. In addition, levels of synaptophysin immunoreactivity in areas 46, 9, and 17 did not differ between 5 nonschizophrenic psychiatric case subjects and their matched controls, suggesting that decreased synaptophysin levels in the prefrontal cortex of patients with schizophrenia may be specific to that disorder. Conclusions: Additional studies are required to determine if the decrease in levels of synaptophysin immunoreactivity is caused by a decrease in the number or size of presynaptic terminals, a decrease in the number of synaptic vesicles per terminal, or a decrease in the expression of synaptophysin. However, all of these potential explanations are consistent with a disturbance in synaptic transmission in the prefrontal cortex of patients with schizophrenia.Keywords
This publication has 42 references indexed in Scilit:
- Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysisJournal of Comparative Neurology, 1995
- Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: I. Remapping of Areas 9 and 46 using Quantitative CriteriaCerebral Cortex, 1995
- Calcium-Dependent Transmitter Secretion Reconstituted in Xenopus Oocytes: Requirement for SynaptophysinScience, 1992
- Quantitative image analysis with densitometry for immunohistochemistry and autoradiography of receptor binding sites—methodological considerationsJournal of Neuroscience Research, 1991
- Mediodorsal nucleus: Areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeysJournal of Comparative Neurology, 1988
- SVP38: A Synaptic Vesicle Protein Whose Appearance Correlates Closely with Synaptogenesis in the Rat Nervous SystemAnnals of the New York Academy of Sciences, 1987
- Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells.The Journal of cell biology, 1986
- Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesiclesCell, 1985
- Interdigitation of Contralateral and Ipsilateral Columnar Projections to Frontal Association Cortex in PrimatesScience, 1982
- Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?Journal of Psychiatric Research, 1982